LY96 and inflammatory bowel disease: The modifications of the SOD mimics led to an improvement of the anti-inflammatory and antioxidant activities in a cellular model, consisting of epithelial intestinal cells HT29-MD2 under LPS-mediated inflammation and relevant to IBD.